Escherichia coli Kl is the most common cause of gram-negative neonatal bacterial meningitis and septicemia. In an attempt to identify genetic markers in E. coli Kl that are associated with the capacity of the organism to cause neonatal meningitis, we used rRNA gene restriction patterns. E. coli strains isolated from the CSF of neonates with meningitis (n = 43) on two continents were compared to strains isolated from the blood of neonates with bacteremia who did not have meningitis (n = 29) and to isolates from the vaginas of asymptomatic pregnant women whose neonates remained without infection (n = 39). E. coli strains from CSF are genetically less heterogeneous than isolates from blood and the vagina: 44.2% of the CSF isolates belonged to only two types, whereas no more than two blood vaginal strains were of the same type. After HindIII digestion, a 14.9-kb rDNAcontaining fragment was found in 81.3% of the strains from CSF vs. 28.0% of the isolates from blood and only 12.8% of the vaginal isolates (P = .001). Thus, genotyping might provide markers to identify organisms in the maternal vaginal flora that are highly likely to cause neonatal meningitis. This observation may have very practical implications for the early identification of these organisms in pregnant women and thus for the selective establishment of preventive measures per partum or for the early treatment of colonized neonates.
Septicemia and meningitis play an increasing part in the morbidity and mortality ofnewborns. The incidence ofneonatal sepsis and meningitis in newborn infants has been estimated to be somewhere between 1 and 5 per 1,000 live births [1] . Escherichia coli is the most common cause of gram-negative bacillary neonatal meningitis and septicemia [2] . Organisms bearing K1 capsular polysaccharide account for 80% of the E. coli involved in neonatal meningitis [2] . Despite antibiotic therapy, morbidity and mortality rates are high and few survivors function normally [3] . It has been estimated that up to 50% of the survivors sustain neurological sequelae and developmental disorders [4] . Thus, neonatal meningitis caused by E. coli remains a significant health problem. A few of the colonized infants are born to K1-negative mothers and presumably acquire E. coli K1 via horizontal transmission from nursery staff members or other infants. But the majority of the infants with meningitis acquire the pathogen from their mother, either at the time of delivery or during the neonatal period [5] .
Previous studies have shown that neonatal sepsis and meningitis are associated with a limited number of clonal groups, in high contrast with the wide genetic heterogeneity of E. coli Kl strains isolated from the feces of children [6] [7] [8] [9] . Thus, we hypothesized that genotyping with the currently available DNA analysis methods might provide markers to rapidly identify organisms in the maternal vaginal flora that might be highly likely to cause neonatal bacteremia and meningitis. To test this hypothesis, we used ribotyping to compare E. coli strains isolated in cases of neonatal meningitis, in cases of neonatal bacteremia, and from cultures of vaginal specimens from asymptomatic pregnant women whose neonates remained without infection.
Materials and Methods
Bacteriology. A total of 111 E. coli isolates were studied. Forty-three strains were recovered from the CSF of 43 neonates with meningitis in different countries on two continents. Of these 43 strains, 24 were isolated from 1990 through 1993 in different regions of France: Paris (14 strains, from three different hospitals), Lyon (1), Pontoise (2), Quimper (1), Nancy (4), Toulouse (1), and Aix-en-Provence (1 [12] .
Ribotyping. Total E. coli DNA was prepared as previously described [13] . It was digested with HindIII or EcoRI and subjected to Southern blotting analysis with ribosomal 16 + 23S RNA from E. coli as a probe [13, 14] . The probe was labeled by random oligopriming with use of a mixture of hexanucleotides (Pharmacia, Uppsala, Sweden) and cloned M-MLV reverse transcriptase (Bethesda Research Laboratories, Gaithersburg, MD) in the presence of 0.35-mM DIG-ll-dUTP (dig oxigenin-ll-deoxyuridine-5' triphosphate; Boehringer, Mannheim, Germany). The procedure for chemiluminescence detection was as previously reported [15] . Isolates showing two or more rDNA-containing fragment differences were considered different types [16] .
Statistical analysis. DNA fragments that were differently distributed among the three groups of strains (CSF, blood, and vaginal isolates) were identified, and the statistical significance of this difference was tested by the X 2 test.
Results
Capsular Kl antigen was found in 80% of E. coli isolates from blood and in 100% of those from CSF samples.
Depending upon the strain, EcoRI and HindIII digestions generated 7 to 12 0.7-24-kb and 6 to 11 1.5-22.5-kb rDNAcontaining fragments, respectively. For the 111 E. coli strains, EcoRI produced 29 fragmentation patterns and HindIII produced 42 patterns. EcoRI and HindIII fragments were combined to define a ribotype. Altogether, 75 different types were observed. Distribution ofthese types was unequal among the three groups of strains: 23 types were found for the 43 CSF strains, as compared with 25 types for the 29 blood isolates and 35 types for the 39 commensal isolates. Remarkably, 42% of the CSF strains belonged to two types only (11 and 8 strains, respectively). These two common ribotypes were found for strains isolated both in Europe (France, Germany, and Finland) and in North America. Two other types were found twice; in both cases the strains were isolated in the same institutions (in Paris and North America, respectively). The remaining 47% of the CSF strains exhibited unique ribotypes. In contrast, for the two other groups of strains (blood and vaginal isolates), no types were shared by more than two strains. Among strains from blood, 72% exhibited unique ribotypes and four ribotypes were found twice. As for the vaginal strains, 79% belonged to unique ribotypes and four ribotypes were found twice. We then conducted a strain-to-strain comparison based upon 
Discussion
Vertical transmission from mother to infant, most likely through the cervix or vagina during delivery, seems to be the most common means of acquisition of E. coli [2, 5] . E. coli Kl is present in the cervix of 5%-7% of pregnant women, and 70% of them convey E. coli to their neonates [18] . Among those infants, about 1% will have a neonatal infection. To date, there is no means of prevention because systematic eradication is unfeasible. Thus, identification of the women (among those carrying the organism) at risk of delivering infants with symptomatic E. coli KI disease is of the utmost interest, because they could be the target of a prevention strategy.
o and H serotyping and multilocus enzyme electrophoresis (MEE) analysis might enable identification of E. coli virulent clones [19] . However, MEE is labor-intensive, and serotyping requires the availability of specific reagents. Because they also explore genetic diversity but at the DNA level, the newly developed genotyping techniques might provide the same type of information while being more appropriate for the routine microbiology laboratory.
In this work, as judged from rDNA restriction patterns, we
found that E. coli strains from cases of neonatal meningitis are genetically less heterogeneous worldwide than strains isolated from blood and vaginal samples from a single hospital. Indeed, 44.2% of CSF strains belonged to only two types (both present on two continents), whereas no more than two blood or vaginal strains were of the same type. In addition, the frequency of some rDNA-containing restriction fragments was significantly increased in the group of CSF strains. These results are in CID 1996;22 (January) kb 23 - agreement with those obtained by MEE analysis and strongly suggest that neonatal meningitis is caused by a restricted number of highly virulent clones or groups of strains sharing common genetic determinants. This conclusion is strengthened by the fact that, on the contrary, strains isolated from the blood of neonates < 1 month of age were as heterogeneous as the commensal strains. Indeed, these strains do not require specific pathogenic potential to cause bacteremia in naturally immunologically immature neonates [20] . Markers derived from studies such as ours might lead the way by genetic linkage to the identification of virulence factors in E. coli. But they also have very practical implications. The presence of the 14.9-kb HindUI fragment was a significant feature of CSF E. coli KI strains, as compared with commensal E. coli Kl strains. This raises the possibility that children of mothers who carry this type of strain may be at increased risk of meningitis. If this is true, then the prior identification of these mothers could lead to effective prevention strategiesincluding eradication per partum, in an attempt to prevent mother-to-infant transmission-and/or early treatment of their neonates. It is feasible to screen the vaginal flora and colonized neonates for strains of E. coli that have KI antigen. Such a routine screening has been performed for more than 6 years in our hospital (at which there are 2,500 deliveries/year), and an average of 130 mothers/year are found to carry E. coli Kl. Thus, 2-3 strains per week would have to be tested by ribotyping for the presence of the 14.9-kb HindUI fragment. Availability of nonradioactive probe labelling kits from commercial sources has now made ribotyping relatively easy to implement in the clinical laboratory, and thus we believe that such an approach is feasible.
-
Over the past few years, DNA analysis techniques developed at research laboratories and increasingly used on a routine basis have become powerful tools in human genetics and microbiology. In the latter field, they have shown their usefulness for epidemiological investigations and, mostly since the advent of PCR, for diagnostic purposes [14, 21, 22] . In human genetics, markers linked to the gene involved in a given disease are used for diagnosis long before the gene itself is identified. Because they are indirect markers and thus subject to an absence/loss of linkage in some individuals, they do not allow a positive diagnosis but an estimation of the risk. The situation we describe here is very similar, and, to our knowledge, this potentiality for genetic markers in infectious diseases has not been addressed yet. Our results illustrate the fact that developing such genetic markers is indeed feasible, even when the nature of virulence is unknown. The 14.9-kb HindIU fragment was also present in 12.8% of the commensal strains; however, one should keep in mind that regardless of the approach one uses, the identification of markers associated with virulence will undoubtedly be obscured by variability of the host's susceptibility or response to the pathogen.
In E. coli, ribotyping provides results similar to those of MEE [23] . However, it might not be the best or the most suitable method in the future. The 14.9-kb HindUI fragment was found in 81.3% ofthe CSF strains. It might be that in some strains, mutational events have altered the suggested genetic linkage between this specific polymorphism and a putative virulence factor, but it might also be that ribotyping cannot generate more specific markers. It is possible that pulse-field gel electrophoresis or random PCR will be more sensitive and more powerful methods to generate such markers. For routine use in laboratories, PCR-based techniques would have the advantage of rapidity and of the fact that only minute quantities of DNA are necessary and not in a purified form. Prospective studies are needed (l) to appreciate the ultimate value of this type of genetic marker for evaluating risk, (2) to determine if identification of a strain with markers of risk could lead to effective preventive measures that would indeed reduce morbidity and mortality rates, and (3) to evaluate the cost-benefit of such analysis.
